Stonepine Capital Management, LLC - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is and the CUSIP is 71426VAK4. A total of 15 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Stonepine Capital Management, LLC ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q3 2016$1,564,000
+13.3%
6,000,0000.0%1.28%
-9.9%
Q2 2016$1,380,0006,000,0001.42%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q3 2016
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 22,760,000$6,745,0001.39%
Telemetry Investments, L.L.C. 9,000,000$1,530,0000.69%
Broadfin Capital, LLC 15,500,000$4,049,0000.49%
Avoro Capital Advisors LLC 6,000,000$1,651,0000.21%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 51,775,000$14,238,0000.21%
Aisling Capital LLC 2,500,000$688,0000.12%
Bruce & Co., Inc. 2,000,000$500,0000.12%
TENOR CAPITAL MANAGEMENT Co., L.P. 2,000,000$582,0000.06%
BARINGS LLC 15,000,000$2,550,0000.03%
ZAZOVE ASSOCIATES LLC 2,000,000$550,0000.03%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders